Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Aug 13, 2026, before the open
10-Q filed Aug 13, 2026, 44 days after period end · 0001493152-26-037576
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $11.38M | $400.00K | — | $3.50M |
| Net Income | -$20.19M | $108.83M | $7.41M | -$16.65M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.35 |
| $1.71 |
| -$0.26 |
| -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.